Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
Volume 0.52M
Average 1.46M
Dividends
Nano-X Imaging Ltd. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does Nano-X Imaging Ltd. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Perspective Therapeutics, Inc. AMEX:CATX | $320.47M | 0.00% | $0.00 | 0.00% | 0.00% |
TriSalus Life Sciences, Inc. NASDAQ:TLSI | $287.25M | 0.00% | $0.00 | 0.00% | 0.00% |
Profound Medical Corp. NASDAQ:PROF | $216.94M | 0.00% | $0.00 | 0.00% | 0.00% |
Inogen, Inc. NASDAQ:INGN | $143.77M | 0.00% | $0.00 | 0.00% | 1.33% |
Solana Company NASDAQ:HSDT | $129.62M | 0.00% | $0.00 | 0.00% | 3.64% |
Health Catalyst, Inc. NASDAQ:HCAT | $125.62M | 0.00% | $0.00 | 0.00% | 0.00% |
MaxCyte, Inc. NASDAQ:MXCT | $124.26M | 0.00% | $0.00 | 0.00% | 0.00% |
Quanterix Corporation NASDAQ:QTRX | $120.59M | 0.00% | $0.00 | 0.00% | 0.45% |
Outset Medical, Inc. NASDAQ:OM | $59.50M | 0.00% | $0.00 | 0.00% | 0.00% |
SANUWAVE Health Inc. NASDAQ:SNWV | $35.26M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about NNOX's dividend, answered from reported figures.
Does NNOX stock pay dividends?
Nano-X Imaging Ltd. (NNOX) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is NNOX's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.